{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T06:15:50Z","timestamp":1778652950240,"version":"3.51.4"},"reference-count":62,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T00:00:00Z","timestamp":1778630400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100010767","name":"Innovative Medicines Initiative","doi-asserted-by":"publisher","award":["115565, 831434"],"award-info":[{"award-number":["115565, 831434"]}],"id":[{"id":"10.13039\/501100010767","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004837","name":"Ministerio de Ciencia e Innovaci\u00f3n","doi-asserted-by":"publisher","award":["IJC2020-043364-I"],"award-info":[{"award-number":["IJC2020-043364-I"]}],"id":[{"id":"10.13039\/501100004837","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Systemic lupus erythematosus (SLE) is a complex autoimmune disease characterized by loss of self-tolerance, causing inflammation and tissue damage in multiple organs. Although animal models have advanced our understanding of SLE\u2019s molecular basis, recent regulatory changes and longstanding concerns regarding reproducibility and translatability have renewed the need to critically evaluate how these models mirror human disease. Understanding pathway-level similarities and differences between mouse models and human disease is essential, given the marked clinical and molecular heterogeneity of SLE.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      Four spontaneous SLE mouse models were studied: MRL\n                      <jats:italic>\n                        <jats:sup>lpr\/lpr<\/jats:sup>\n                      <\/jats:italic>\n                      , NZB\/W, BXSB.\n                      <jats:italic>Yaa<\/jats:italic>\n                      , and Tlr7.Tg6. Transcriptome sequencing from blood, spleen, and kidney; flow cytometry from the spleen; and cytokines and autoantibody measurement in plasma were performed at four time points. Similar molecular datasets from the human PRECISESADS SLE cohort were used for the integration.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      The study identified specific molecular pathways driving the phenotype in each mouse model and established a framework describing the dynamics of these phenotype-associated molecular signatures, thereby facilitating the selection of time points of interest for future mouse-oriented experimental designs. In addition, by comparing these pathways with those observed in human SLE, we identified the most similar ones and their relationship with disease activity, providing crucial insight into their translational relevance. Importantly, disease severity across models was linked to both the extent and timing of molecular dysregulations. As expected, MRL\n                      <jats:italic>\n                        <jats:sup>lpr\/lpr<\/jats:sup>\n                      <\/jats:italic>\n                      showed the most aggressive phenotype with early immune activation and apoptosis dysregulation, while Tlr7.Tg6 presented late-onset signatures associated with interferon and inflammation. Shared molecular features with human SLE included interferon responses, T and B cell depletion, and neutrophil activation. Integration analysis revealed distinct, yet overlapping, immune pathways between models and species, with some signatures such as age-associated B cells and double-negative memory T cells being model-specific but potentially relevant to early disease processes.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>These findings provide a valuable framework for future SLE research and reinforce the utility of mouse models for studying specific molecular pathways related to human SLE pathogenesis and heterogeneity. The integration of longitudinal mouse and human molecular information highlights the models that best recapitulate key aspects of human disease, offering guidance for the study of specific immunopathological mechanisms or therapeutic targets.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fimmu.2026.1823650","type":"journal-article","created":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T05:56:54Z","timestamp":1778651814000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Assessing the translational relevance of specific molecular pathways in spontaneous lupus mouse models"],"prefix":"10.3389","volume":"17","author":[{"given":"Mar\u00eda","family":"Rivas-Torrubia","sequence":"first","affiliation":[{"name":"Genyo. Pfizer\u2013University of Granada\u2013Junta de Andaluc\u00eda Centre for Genomics and Oncological Research","place":["Granada, Spain"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00eda","family":"Morell","sequence":"additional","affiliation":[{"name":"Genyo. Pfizer\u2013University of Granada\u2013Junta de Andaluc\u00eda Centre for Genomics and Oncological Research","place":["Granada, Spain"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zuzanna","family":"Makowska","sequence":"additional","affiliation":[{"name":"Bayer Pharma AG","place":["Berlin, Berlin, Germany"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jorge","family":"Kageyama","sequence":"additional","affiliation":[{"name":"Bayer Pharma AG","place":["Berlin, Berlin, Germany"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anne","family":"Bosshard","sequence":"additional","affiliation":[{"name":"Bayer Pharma AG","place":["Berlin, Berlin, Germany"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julius","family":"Lindblom","sequence":"additional","affiliation":[{"name":"Division of Rheumatology, Department of Medicine Solna, Karolinska Institutet and Karolinska University Hospital","place":["Stockholm, Sweden"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Orietta","family":"Borghi","sequence":"additional","affiliation":[{"name":"Immunorheumatology Research Laboratory, IRCCS Istituto Auxologico Italiano","place":["Milan, Italy"]},{"name":"Department of Clinical Sciences and Community Health, University of Milan","place":["Milan, Italy"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eleonore","family":"Bettacchioli","sequence":"additional","affiliation":[{"name":"Lymphocytes B, Autoimmunit\u00e9 et Immunoth\u00e9rapies (LBAI), UMR 1227, Institut National de la Sant\u00e9 et de la Recherche M\u00e9dicale (INSERM), University of Western Brittany","place":["Brest, France"]},{"name":"Department of Immunology and Immunotherapy Laboratory, University-Hospital of Brest","place":["Brest, France"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"PRECISESADS flow cytometry consortium","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"PRECISESADS clinical consortium","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ioannis","family":"Parodis","sequence":"additional","affiliation":[{"name":"Genyo. Pfizer\u2013University of Granada\u2013Junta de Andaluc\u00eda Centre for Genomics and Oncological Research","place":["Granada, Spain"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lorenzo","family":"Beretta","sequence":"additional","affiliation":[{"name":"Genyo. Pfizer\u2013University of Granada\u2013Junta de Andaluc\u00eda Centre for Genomics and Oncological Research","place":["Granada, Spain"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Concepci\u00f3n","family":"Mara\u00f1\u00f3n","sequence":"additional","affiliation":[{"name":"Division of Rheumatology, Department of Medicine Solna, Karolinska Institutet and Karolinska University Hospital","place":["Stockholm, Sweden"]},{"name":"Department of Rheumatology, Faculty of Medicine and Health, \u00d6rebro University","place":["\u00d6rebro, Sweden"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jacques-Olivier","family":"Pers","sequence":"additional","affiliation":[{"name":"Referral Center for Systemic Autoimmune Diseases, Fondazione IRCCS Ca\u2019 Granda Ospedale Maggiore Policlinico di Milano","place":["Milano, Italy"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ralf","family":"Lesche","sequence":"additional","affiliation":[{"name":"Genyo. Pfizer\u2013University of Granada\u2013Junta de Andaluc\u00eda Centre for Genomics and Oncological Research","place":["Granada, Spain"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fiona","family":"McDonald","sequence":"additional","affiliation":[{"name":"Lymphocytes B, Autoimmunit\u00e9 et Immunoth\u00e9rapies (LBAI), UMR 1227, Institut National de la Sant\u00e9 et de la Recherche M\u00e9dicale (INSERM), University of Western Brittany","place":["Brest, France"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marta E.","family":"Alarc\u00f3n-Riquelme","sequence":"additional","affiliation":[{"name":"Bayer Pharma AG","place":["Berlin, Berlin, Germany"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guillermo","family":"Barturen","sequence":"additional","affiliation":[{"name":"Bayer Pharma AG","place":["Berlin, Berlin, Germany"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2026,5,13]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1126\/science.adg6276","article-title":"Fda no longer has to require animal testing for new drugs","volume":"379","author":"Wadman","year":"2023","journal-title":"Science"},{"key":"B2","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1038\/nrrheum.2017.220","article-title":"Moving towards a molecular taxonomy of autoimmune rheumatic diseases","volume":"14","author":"Barturen","year":"2018","journal-title":"Nat Rev Rheumatol"},{"key":"B3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/nrdp.2016.39","article-title":"Systemic lupus erythematosus","volume":"2","author":"Kaul","year":"2016","journal-title":"Nat Rev Dis Primer"},{"key":"B4","doi-asserted-by":"publisher","first-page":"1480","DOI":"10.1001\/jama.2024.2315","article-title":"Systemic lupus erythematosus: a review","volume":"331","author":"Siegel","year":"2024","journal-title":"JAMA"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2016.03.008","article-title":"Personalized immunomonitoring uncovers molecular networks that stratify lupus patients","volume":"165","author":"Banchereau","year":"2016","journal-title":"Cell"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1002\/art.40653","article-title":"Stratification of systemic lupus erythematosus patients into three groups of disease activity progression according to longitudinal gene expression","volume":"70","author":"Toro-Dom\u00ednguez","year":"2018","journal-title":"Arthritis Rheumatol"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1002\/art.41610","article-title":"Integrative analysis reveals a molecular stratification of systemic autoimmune diseases","volume":"73","author":"Barturen","year":"2021","journal-title":"Arthritis Rheumatol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1177\/0961203316652492","article-title":"A critical review of clinical trials in systemic lupus erythematosus","volume":"25","author":"Mahieu","year":"2016","journal-title":"Lupus"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1155\/2011\/271694","article-title":"Murine models of systemic lupus erythematosus","volume":"2011","author":"Perry","year":"2011","journal-title":"BioMed Res Int"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1080\/08916934.2025.2531766","article-title":"Role of animal models in understanding the mechanisms of autoimmune diseases","volume":"58","author":"Khan","year":"2025","journal-title":"Autoimmunity"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaut.2020.102490","article-title":"Are lupus animal models useful for understanding and developing new therapies for human SLE","volume":"112","author":"Moore","year":"2020","journal-title":"J Autoimmun"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1080\/08916934.2024.2319203","article-title":"Animal models of lupus nephritis: the past, present and a future outlook","volume":"57","author":"Katikaneni","year":"2024","journal-title":"Autoimmunity"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1080\/08916934.2024.2330387","article-title":"Animal models of neuropsychiatric systemic lupus erythematosus: deciphering the complexity and guiding therapeutic development","volume":"57","author":"Polis","year":"2024","journal-title":"Autoimmunity"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25105351","article-title":"Human and murine toll-like receptor-driven disease in systemic lupus erythematosus","volume":"25","author":"Von Hofsten","year":"2024","journal-title":"Int J Mol Sci"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2007.09.009","article-title":"Control of toll-like receptor 7 expression is essential to restrict autoimmunity and dendritic cell proliferation","volume":"27","author":"Deane","year":"2007","journal-title":"Immunity"},{"key":"B16","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1097\/BOR.0000000000000412","article-title":"An update on lupus animal models","volume":"29","author":"Li","year":"2017","journal-title":"Curr Opin Rheumatol"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.14806\/ej.17.1.200","article-title":"Cutadapt removes adapter sequences from high-throughput sequencing reads","volume":"17","author":"Martin","year":"2011","journal-title":"EMBnetjournal"},{"key":"B18","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1093\/bioinformatics\/bts635","article-title":"Star: ultrafast universal RNA-seq aligner","volume":"29","author":"Dobin","year":"2013","journal-title":"Bioinformatics"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2105-12-323","article-title":"Rsem: accurate transcript quantification from RNA-seq data with or without a reference genome","volume":"12","author":"Li","year":"2011","journal-title":"BMC Bioinf"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gky955","article-title":"Gencode reference annotation for the human and mouse genomes","volume":"47","author":"Frankish","year":"2019","journal-title":"Nucleic Acids Res"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2016.07.034","article-title":"Multi-center harmonization of flow cytometers in the context of the European \u201cPRECISESADS\u201d project","volume":"15","author":"Jamin","year":"2016","journal-title":"Autoimmun Rev"},{"key":"B22","article-title":"FlowJoTM software","year":"2023"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-014-0550-8","article-title":"Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2","volume":"15","author":"Love","year":"2014","journal-title":"Genome Biol"},{"key":"B24","doi-asserted-by":"publisher","first-page":"Undefined","DOI":"10.1186\/1471-2105-14-7","article-title":"Gsva: gene set variation analysis for microarray and RNA-seq data","volume":"14","author":"H\u00e4nzelmann","year":"2013","journal-title":"BMC Bioinf"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1093\/bioinformatics\/btab121","article-title":"BloodGen3Module: blood transcriptional module repertoire analysis and visualization using R","volume":"37","author":"Rinchai","year":"2021","journal-title":"Bioinformatics"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkab1112","article-title":"Database resources of the national center for biotechnology information","volume":"50","author":"Sayers","year":"2022","journal-title":"Nucleic Acids Res"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1016\/j.xinn.2021.100141","article-title":"ClusterProfiler 4.0: a universal enrichment tool for interpreting omics data","volume":"2","author":"Wu","year":"2021","journal-title":"Innov Camb Mass"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1016\/j.cels.2015.12.004","article-title":"The molecular signatures database hallmark gene set collection","volume":"1","author":"Liberzon","year":"2015","journal-title":"Cell Syst"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1038\/s41592-021-01343-9","article-title":"Identifying temporal and spatial patterns of variation from multimodal data using MEFISTO","volume":"19","author":"Velten","year":"2022","journal-title":"Nat Methods"},{"key":"B30","article-title":"Assessing remission in systemic lupus erythematosus","volume":"24","author":"Mosca","year":"2006","journal-title":"Clin Exp Rheumatol"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780340802","article-title":"Definition, incidence, and clinical description of flare in systemic lupus erythematosus. a prospective cohort study","volume":"34","author":"Petri","year":"1991","journal-title":"Arthritis Rheum"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.181.12.8761","article-title":"Expanded double negative T cells in patients with systemic lupus erythematosus produce IL-17 and infiltrate the kidneys1","volume":"181","author":"Crisp\u00edn","year":"2008","journal-title":"J Immunol"},{"key":"B33","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1089\/jir.2015.0093","article-title":"Interleukin-2 enhances the regulatory functions of CD4(+)T cell-derived CD4(-)CD8(-) double negative T cells","volume":"36","author":"Cong","year":"2016","journal-title":"J Interferon Cytokine Res Off J Int Soc Interferon Cytokine Res"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.148.9.2764","article-title":"Macrophage inflammatory protein 1 modulates macrophage function","volume":"148","author":"Fahey","year":"1992","journal-title":"J Immunol Baltim Md 1950"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1084\/jem.176.6.1489","article-title":"RANTES and macrophage inflammatory protein 1 alpha induce the migration and activation of normal human eosinophil granulocytes","volume":"176","author":"Rot","year":"1992","journal-title":"J Exp Med"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1101044","article-title":"Dendritic cells activated by IFN-\u03b3\/STAT1 express IL-31 receptor and release proinflammatory mediators upon IL-31 treatment","volume":"188","author":"Horejs-Hoeck","year":"2012","journal-title":"J Immunol Baltim Md 1950"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1093\/intimm\/dxq027","article-title":"Activation of human eosinophils and epidermal keratinocytes by Th2 cytokine IL-31: implication for the immunopathogenesis of atopic dermatitis","volume":"22","author":"Cheung","year":"2010","journal-title":"Int Immunol"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.180.10.6846","article-title":"Additive roles for MCP-1 and MCP-3 in CCR2-mediated recruitment of inflammatory monocytes during Listeria monocytogenes infection","volume":"180","author":"Jia","year":"2008","journal-title":"J Immunol Baltim Md 1950"},{"key":"B39","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41392-023-01452-1","article-title":"Macrophages in immunoregulation and therapeutics","volume":"8","author":"Chen","year":"2023","journal-title":"Signal Transd Targ Ther"},{"key":"B40","doi-asserted-by":"publisher","first-page":"7","DOI":"10.4049\/jimmunol.2300094","article-title":"The world according to IL-9","volume":"211","author":"Pajulas","year":"2023","journal-title":"J Immunol"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1111\/cei.12380","article-title":"Pathogenetic role of glomerular CXCL13 expression in lupus nephritis","volume":"178","author":"Worthmann","year":"2014","journal-title":"Clin Exp Immunol"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1657350","article-title":"The utility of CXCL13 and circulating CXCR5+ T cell detection in the diagnosis of systemic lupus erythematosus associated nephritis","volume":"16","author":"Liu","year":"2025","journal-title":"Front Immunol"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1016\/B978-0-12-811710-1.00008-2","article-title":"Animal models for human disease","author":"Reza Khorramizadeh","year":"2020","journal-title":"Anim Biotechnol"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1084\/jem.148.5.1198","article-title":"Spontaneous murine lupus-like syndromes. clinical and immunopathological manifestations in several strains","volume":"148","author":"Andrews","year":"1978","journal-title":"J Exp Med"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.94.26.14654","article-title":"Role of the major histocompatibility complex class II Ea gene in lupus susceptibility in\u2009mice","volume":"94","author":"Ibnou-Zekri","year":"1997","journal-title":"Proc Natl Acad Sci"},{"key":"B46","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1007\/s00018-022-04433-9","article-title":"Age-associated B cells in autoimmune diseases","volume":"79","author":"Mouat","year":"2022","journal-title":"Cell Mol Life Sci"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20221346","article-title":"Age-associated B cells are heterogeneous and dynamic drivers of autoimmunity in mice","volume":"220","author":"Nickerson","year":"2023","journal-title":"J Exp Med"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1136\/lupus-2022-000660","article-title":"Phenotypical changes and clinical significance of CD4+\/CD8+ T cells in SLE","volume":"9","author":"Yuan","year":"2022","journal-title":"Lupus Sci Med"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20021553","article-title":"Interferon and granulopoiesis signatures in systemic lupus erythematosus blood","volume":"197","author":"Bennett","year":"2003","journal-title":"J Exp Med"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2008.05.012","article-title":"A modular analysis framework for blood genomics studies: application to systemic lupus erythematosus","volume":"29","author":"Chaussabel","year":"2008","journal-title":"Immunity"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1093\/bib\/bbac332","article-title":"Scoring personalized molecular portraits identify systemic lupus erythematosus subtypes and predict individualized drug responses, symptomatology and disease progression","volume":"23","author":"Toro-Dom\u00ednguez","year":"2022","journal-title":"Brief Bioinform"},{"key":"B52","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1097\/RHU.0000000000000581","article-title":"Type III interferons in systemic lupus erythematosus: Association between interferon \u03bb3, disease activity, and anti-Ro\/SSA antibodies","volume":"23","author":"Amezcua-Guerra","year":"2017","journal-title":"JCR J Clin Rheumatol"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.01686","article-title":"Shared and unique patterns of DNA methylation in systemic lupus erythematosus and primary Sj\u00f6gren\u2019s syndrome","volume":"10","author":"Imgenberg-Kreuz","year":"2019","journal-title":"Front Immunol"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1908576116","article-title":"Transcriptomic, epigenetic, and functional analyses implicate neutrophil diversity in the pathogenesis of systemic lupus erythematosus","volume":"116","author":"Mistry","year":"2019","journal-title":"Proc Natl Acad Sci"},{"key":"B55","doi-asserted-by":"publisher","first-page":"8133","DOI":"10.1038\/s41467-023-43573-9","article-title":"Human and mouse neutrophils share core transcriptional programs in both homeostatic and inflamed contexts","volume":"14","author":"Hackert","year":"2023","journal-title":"Nat Commun"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1016\/0952-7915(94)90013-2","article-title":"Apoptosis, fas and systemic autoimmunity: the MRL-Ipr\/Ipr model","volume":"6","author":"Singer","year":"1994","journal-title":"Curr Opin Immunol"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1101602","article-title":"Enhanced phosphoinositide 3-kinase \u03b4 activity is a frequent event in systemic lupus erythematosus that confers resistance to activation-induced T cell death","volume":"187","author":"Su\u00e1rez-Fueyo","year":"2011","journal-title":"J Immunol"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2009-04-216770","article-title":"TLR7 stimulation in human plasmacytoid dendritic cells leads to the induction of early IFN-inducible genes in the absence of type I IFN","volume":"114","author":"Di Domizio","year":"2009","journal-title":"Blood"},{"key":"B59","doi-asserted-by":"publisher","first-page":"5947","DOI":"10.1038\/s41467-021-26099-w","article-title":"Interleukin-31 promotes fibrosis and T helper 2 polarization in systemic sclerosis","volume":"12","author":"Kuzumi","year":"2021","journal-title":"Nat Commun"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20101048","article-title":"Autoimmune skin inflammation is dependent on plasmacytoid dendritic cell activation by nucleic acids via TLR7 and TLR9","volume":"207","author":"Guiducci","year":"2010","journal-title":"J Exp Med"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1038\/sj.gene.6364424","article-title":"Monocytosis in BXSB mice is due to epistasis between Yaa and the telomeric region of chromosome 1 but does not drive the disease process","volume":"8","author":"Rogers","year":"2007","journal-title":"Genes Immun"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.172.8.5047","article-title":"Strain distribution pattern of susceptibility to immune-mediated nephritis","volume":"172","author":"Xie","year":"2004","journal-title":"J Immunol"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1823650\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T05:56:56Z","timestamp":1778651816000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1823650\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,13]]},"references-count":62,"alternative-id":["10.3389\/fimmu.2026.1823650"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2026.1823650","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,13]]},"article-number":"1823650"}}